Design Therapeutics, Inc. (DSGN)
NASDAQ: DSGN · Real-Time Price · USD
10.21
+0.16 (1.59%)
Mar 9, 2026, 1:22 PM EDT - Market open

Design Therapeutics Market Cap

Design Therapeutics has a market cap or net worth of $581.60 million as of March 9, 2026. Its market cap has increased by 105.03% in one year.

Market Cap
581.60M
Enterprise Value
376.23M
1-Year Change
105.03%
Ranking
Category
Stock Price
$10.21

Market Cap Chart

Since the IPO on March 26, 2021, Design Therapeutics's market cap has decreased from $2.21B to $581.60M, a decrease of -73.64%. That is a compound annual growth rate of -23.62%.

History

DateMarket Cap% Change
Mar 6, 2026572.49M7.14%
Dec 31, 2025534.32M52.95%
Dec 31, 2024349.35M135.41%
Dec 29, 2023148.40M-74.10%
Dec 30, 2022572.92M-51.55%
Dec 31, 20211.18B-46.40%

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
LB Pharmaceuticals 601.61M
enGene Holdings 581.47M
YD Bio 573.10M
Larimar Therapeutics 566.84M
MeiraGTx Holdings 563.44M
Verastem 560.39M
Alpha Tau Medical 546.54M
Fulcrum Therapeutics 544.12M
Market Cap Rankings